0001127602-22-012868.txt : 20220502 0001127602-22-012868.hdr.sgml : 20220502 20220502172444 ACCESSION NUMBER: 0001127602-22-012868 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220428 FILED AS OF DATE: 20220502 DATE AS OF CHANGE: 20220502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferruzzi Mario CENTRAL INDEX KEY: 0001659317 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07626 FILM NUMBER: 22883377 MAIL ADDRESS: STREET 1: 777 E. WISCONSIN AVENUE CITY: MILWAUKEE STATE: WI ZIP: 53202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SENSIENT TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000310142 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 390561070 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 EAST WISCONSIN AVENUE CITY: MILWAUKEE STATE: WI ZIP: 53202-5304 BUSINESS PHONE: 4142716755 MAIL ADDRESS: STREET 1: 777 EAST WISCONSIN AVENUE CITY: MILWAUKEE STATE: WI ZIP: 53202-5304 FORMER COMPANY: FORMER CONFORMED NAME: UNIVERSAL FOODS CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-04-28 0000310142 SENSIENT TECHNOLOGIES CORP SXT 0001659317 Ferruzzi Mario 777 E. WISCONSIN AVENUE MILWAUKEE WI 53202 1 Common Stock 2022-04-28 4 A 0 1060 0 A 7589.676 D Common Stock 2022-04-28 4 F 0 665 84.98 D 6924.676 D Common Stock 209.576 I Spouse's ESOP Deferred Stock Common Stock 1968.096 1968.096 D Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing. Deferred stock converts to common stock on a one-for-one basis. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. /s/ John J. Manning, Attorney-in-Fact for Dr. Ferruzzi 2022-05-02